On Sept. 12, 2016, Cowen and Company (Nasdaq:COWN) released a report on the near- and long-term market potential of legal recreational cannabis in the United States, estimating that a federally legal U.S. cannabis market could reach $50 billion in gross retail sales by 2026.
It’s no longer a secret that the cannabis industry is growing in a big way. In a remarkably short amount of time, cannabis has already been fully legalized in five states.
Many companies directly in or serving the cannabis industry have turned to the public markets in order to facilitate raising capital.
While investment in cannabis industries is limited in the U.S. by federal law, Canadian companies and investors don’t face these same restrictions.
Interested in taking part of Oregon’s upcoming recreational marijuana market? While the entry barriers for dispensaries in Oregon aren’t as high they are in other states, it still takes a sizable investment to enter the business. And to get funding, companies must be prepared.
On Nov. 12, 2015, the Colorado Division of Securities issued an investor alert titled, “Are you an Informed Investor? The Next Big Thing.” The alert addressed the popularity of investments in marijuana, binary options and digital currencies.
Randy Shipley, the founder and CEO of CannaFundr.com, is among those who believe that the new SEC rules will “potentially” have a positive influence on the marijuana industry.
Cannabis is in a unique situation of potential exponential growth both from the financial standpoint and the research and development standpoint, but has to trade in a market place with a dubious reputation.
On July 9, 2015, the Securities and Exchange Commission announced that it had settled charges against Alexander Hawatmeh and Christopher Mrowca. So far, so good, but is the legal marijuana industry any safer for investors?
Always on the lookout for ways investors are participating the cannabis space, today we are taking a look at a publicly traded company that, on the surface, offers a unique access point.
If you can forgive the rather liberal stretching of the analogy here, there are a lot of correlations between cannabis as an industry and this key stage of human development.
Would you like to invest in Uber? Or how about Airbnb? Well it turns out that you can’t. If you’re a regular Joe or Jane investor, there are no shares to buy for either company, or for companies like Pinterest and SpaceX.
Starting a new business is complicated enough – company founders have to find a place to set up shop, hire great employees, manage cash flow, market their goods or services and sometimes hire experts to help.
Quotations can connect you to wisdom from the past that you can apply to the present and the future. Many of the legal marijuana industry’s key players have already amassed vital wisdom during the industry’s fledgling years.
Ever since the SEC cracked down on marijuana-related investments in 2014, potential investors have been painfully aware of the need to conduct adequate due diligence on the early-stage companies that come courting.
More than 115 early-stage startups applied for one of 10 spots within CanopyBoulder’s spring business accelerator program for the legal cannabis industry.
Public stock investors in the cannabis industry are largely relegated to the over-the-counter marketplace. This is much different from stocks trading on an exchange, and far less expensive for companies to access.
Even in the wake of warnings from the SEC regarding fraudulent marijuana stocks, investors are still seeking ways to capitalize on the “green rush.”
Given the title of yesterday’s Market Musings piece and the subject of today’s, you, dear reader, could be forgiven for thinking that I have some kind of a drug problem. I can assure you that I don’t. I just have a problem with some drug stocks, both the non-conventional and more traditional.
Canada’s securities watchdogs are warning investors to be wary of publicly traded companies with ambitions to grow and sell medical marijuana after a rush of at least 13 firms into the industry.
Following its transfer to droop a fifth microcap firm that claims to be engaged within the rising marijuana business, U.S. securities regulators issued a warning to investors about the danger of fraud within the area. Proper information regarding trade within the marijuana sector may be withheld from hungry investors, the SEC warns. VIEW FULL ARTICLE
When the SEC temporarily suspended the trading of GrowLife securities (OTCMKTS: PHOT) on April 10, it sounded an official fire alarm. Maybe GrowLife was simply sending smoke signals, but the SEC’s suspension was lifted yesterday and it appears many investors feared the company was in flames. Forbes reported stocks plummeting 60 percent before lunchtime and by close of trading, the stocks were down 58.17 percent.
Faulty information regarding the legitimacy marijuana marketplace information has given way to GrowLife’s (PHOT) plummeting shares.
B.C. investors be forewarned about the green rush: the budding marijuana enterprise holds some inconspicuous business scams.
Scam artists leave investors high and dry after having poured their money into, what they believed to be, a promising market share.
Investors: Don’t be fooled, stock promises for “high” returns are often broken.
Stocks in CannaVest are soaring high and, as Forbes puts it, “the world’s leading hemp-based investment company”.
Alert! Marijuana stock scams are prevalent, so beware of “hot” stocks. You don’t want your portfolio burning faster than a blunt.
A recent surge of marijuana stocks makes it seem as though investing into any pot-related business would be smart, right? Wrong. Experts encourage investors to do their homework before jumping on the greenest bandwagon in history.
SALT LAKE CITY — Authorities warn of investment scams